Figure 1From: Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma Disease course of mRCC patients refractory to first rTKI treatment. PD - progressive disease; SD - stable disease; ST - sequential therapy; BSC - best supportive care; rTKI - receptor tyrosine kinase inhibitor.Back to article page